Innovation in myeloma treatments PARP excellence!

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations


In this issue of Blood, Neri and colleagues report a promising treatment of myeloma using a combination of bortezomib plus inhibition of the enzyme PARP1 (REF). 1This is welcome news, as new avenues for the treatment of the disease are needed.

Original languageEnglish (US)
Pages (from-to)6234-6235
Number of pages2
Issue number24
StatePublished - Dec 8 2011

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Innovation in myeloma treatments PARP excellence!'. Together they form a unique fingerprint.

Cite this